Dian Diagnostics Group Co.,Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 300244.SZ | DIA.MI | QGEN | 300406.SZ | EYWN.F | 300676.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 13.78B | 4.02B | 10.50B | 7.50B | 11.46B | 16.52B |
| P/E (TTM) | 28.6 | 30.0 | 25.8 | 29.7 | 25.0 | — |
| Forward P/E | 31.3 | 18.8 | 19.5 | 10.6 | — | 246.9 |
| Price/book | 2.0 | 2.8 | 3.1 | 2.1 | 2.7 | 2.0 |
| Dividend yield | 1.69% | 1.58% | 0.69% | 8.29% | 1.09% | — |
| 1-year change | +26.44% | +36.24% | +18.04% | −7.11% | −12.44% | −21.90% |
| Today | +6.73% | −0.73% | +0.89% | +0.95% | +3.23% | +3.54% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All 300244.SZ news ›Profit has skyrocketed by 750%, is Dian Diagnostics staging a dominant comeback?
On the evening of October 19, Dian Diagnostics released its 2026 Q3 financial report. At first glance, one data point stands out remarkably. The net profit attributable to shareholders for the first three quarters reached 482 million yuan,…
From the 4Search news index, newest first.
In the news
People in the coverage
Themes
Most coverage from
- eu.36kr.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.